Third Quarter 2026 and Recent Business Highlights
Lightbridge was selected for the DOE Nuclear Energy Launch Pad INL program. InAugust 2026 ,Lightbridge was selected to participate in the program, which is administered byDOE's National Reactor Innovation Center (NRIC) atIdaho National Laboratory (INL). Selection provides an accelerated pathway towardDOE authorization for the Company to design, build, and operate the Lightbridge Fuel™Pilot Factory (Pilot Factory ), which the Company also refers to as SHED, at INL to manufacture lead test assemblies (LTAs) of Lightbridge Fuel™ for demonstration inU.S . commercial power reactors. The Company is negotiating the applicable agreements and project scope with NRIC and INL. Authorization to construct and operate thePilot Factory remains subject to additionalDOE /INL agreements, reviews, and authorizations.- Secured loop irradiation testing of clad fuel rodlets in the Advanced Test Reactor (ATR). In
August 2026 , the Company entered into Project Task Statement (PTS) No. 2 under itsCooperative Research and Development Agreement (CRADA) withBattelle Energy Alliance, LLC (BEA), theDOE operating contractor for INL. The work covers experimental design, materials, assembly, irradiation, shipment, and disposition of enriched uranium-zirconium fuel rodlets with cladding, in both cylindrical and multi-lobe geometries, irradiated in the ATR loop facility under controlled conditions representative of a commercial reactor. - Post-irradiation examination of the first fuel samples is currently underway. The first batch of Lightbridge Fuel™ material coupon samples, discharged from the ATR on schedule in
May 2026 , is currently undergoing post-irradiation examination at INL. - Expanded patent protection in
Japan . InSeptember 2026 , the Japan Patent Office issued a notice of allowance for the Company's multi-zone fuel element patent application, with allowed claims covering the fuel element design, a fuel assembly containing it, and an additive manufacturing method for producing it.Japan operates 32 reactors, 15 of which have returned to service, and its national energy plan targets nuclear at approximately 20% of electricity generation by fiscal 2040.
Management Commentary
“Selection for the Launch Pad INL program can help to accelerate our commercialization plan,” said
“Our path to acceleration comes at a pivotal moment for the nuclear sector, as major technology companies and utilities increasingly turn to nuclear energy to meet surging baseload power demand from AI, data centers, and industrial electrification. This requires getting substantially more power and higher capacity factors out of the existing nuclear fleet, alongside new builds. Utilities consistently tell us they want three things from an advanced fuel: longer operating cycles between refuelings, power uprates of 10% to 20% from the same plant footprint and operating license, and inherent safety margins that reduce capital and operating costs. Lightbridge Fuel is engineered specifically to meet those requirements.”
Financial Highlights
Working capital was approximately
Cash Flows Summary
Cash and cash equivalents totaled
- Net cash used in operating activities was
$13.2 million for the nine months endedSeptember 30, 2026 , compared to$8.1 million for the nine months endedSeptember 30, 2025 , reflecting higher research and development (R&D) and general and administrative (G&A) spending, partially offset by higher interest income. - Net cash provided by financing activities was
$48.1 million for the nine months endedSeptember 30, 2026 , compared to$121.4 million for the same period in 2025. The Company sold approximately 4.3 million shares of common stock under its at-the-market (ATM) program during the nine months endedSeptember 30, 2026 , for net proceeds of$48.9 million , including 579,685 shares for net proceeds of$4.5 million in the third quarter. As ofSeptember 30, 2026 , approximately$91.4 million of common stock remained available for sale under the Company's$150 million ATM program.
Third Quarter 2026 Operations Summary
- G&A expenses were
$5.0 million for the three months endedSeptember 30, 2026 , compared to$3.2 million for the three months endedSeptember 30, 2025 . The$1.8 million increase reflects a$0.9 million increase in employee compensation and stock-based compensation for employees, contractors, and directors, driven by new hires, higher bonuses, and new stock-based awards; a$0.7 million increase in professional and consulting services; and a$0.2 million increase in other administrative expenses, including information technology, insurance, patent, and travel costs. - R&D expenses were
$5.3 million for the three months endedSeptember 30, 2026 , compared to$2.0 million for the three months endedSeptember 30, 2025 . The$3.3 million increase reflects a$1.9 million increase in employee compensation and stock-based compensation from new hires, higher bonuses, and new stock-based awards; a$1.0 million increase in information technology expenses, primarily computer software and operating costs for the Company's high-performance computer; and a$0.4 million increase in INL project costs as the Company entered into additional agreement modifications and new PTSs. - Total non-cash stock-based compensation expense was
$2.4 million for the three months endedSeptember 30, 2026 , compared to$1.6 million for the three months endedSeptember 30, 2025 . Stock-based compensation included in G&A was$1.6 million , compared to$1.1 million in the prior-year quarter. Stock-based compensation included in R&D was$0.8 million , compared to$0.5 million in the prior-year quarter. - Other income was
$2.0 million for the three months endedSeptember 30, 2026 , compared to$1.1 million for the three months endedSeptember 30, 2025 , consisting of interest income earned on higher cash balances invested primarily inU.S .Treasury bills. - Net loss was
$8.3 million , or$(0.23) per basic and diluted share, for the three months endedSeptember 30, 2026 , compared to a net loss of$4.1 million , or$(0.16) per basic and diluted share, for the three months endedSeptember 30, 2025 .
Nine Months Ended
G&A expenses were
- R&D expenses were
$12.6 million for the nine months endedSeptember 30, 2026 , compared to$5.3 million for the nine months endedSeptember 30, 2025 . The$7.3 million increase reflects a$4.3 million increase in employee compensation and stock-based compensation; a$1.7 million increase in information technology expenses, including software, operating costs for the Company's high-performance computer, and code development; a$0.6 million increase in INL project costs; a$0.4 million increase in project development costs, primarily critical heat flux testing and safety analysis; and a$0.3 million increase in other outside R&D expenses. - Total non-cash stock-based compensation expense was
$6.3 million for the nine months endedSeptember 30, 2026 , compared to$3.6 million for the nine months endedSeptember 30, 2025 . Stock-based compensation included in G&A was$4.4 million , compared to$2.7 million in the prior period. Stock-based compensation included in R&D was$1.9 million , compared to$0.9 million in the prior period. The 2026 total stock-based compensation expense included a$0.7 million reversal recorded in the second quarter of previously recognized stock-based compensation for a performance milestone no longer deemed probable of achievement, of which$0.5 million was included in G&A and$0.2 million was included in R&D. - Other income was
$5.2 million for the nine months endedSeptember 30, 2026 , compared to$2.1 million for the nine months endedSeptember 30, 2025 . - Net loss was
$20.4 million , or$(0.62) per basic and diluted share, for the nine months endedSeptember 30, 2026 , compared to a net loss of$12.4 million , or$(0.55) per basic and diluted share, for the nine months endedSeptember 30, 2025 .
CONFERENCE CALL & AUDIO WEBCAST
To access the call by phone, please dial 1-800-715-9871 (International dialers can dial 1-646-307-1963) with Conference ID 8688160. To avoid delays, we encourage participants to dial in to the conference call 15 minutes before the scheduled start time and have the Conference ID handy.
An audio webcast can be accessed at the following link (webcast). The Company encourages participants to take advantage of the webcast option.
A webcast replay will also be available for a limited time at the following link (webcast replay).
About Lightbridge Corporation
Lightbridge Corporation (Nasdaq: LTBR) is focused on developing advanced nuclear fuel technology essential to delivering abundant clean energy and providing energy security to the world. The Company is developing Lightbridge Fuel™, a proprietary next-generation nuclear fuel technology for existing light water reactors and pressurized heavy water reactors, significantly enhancing reactor safety, economics, and proliferation resistance. The Company is also developing Lightbridge Fuel for new small modular reactors to deliver the same benefits, plus load-following.
Lightbridge has entered into two long-term framework agreements with Battelle Energy Alliance, LLC, the United States Department of Energy’s operating contractor for Idaho National Laboratory, the United States’ lead nuclear energy research and development laboratory. DOE’s Gateway for Accelerated Innovation in Nuclear program has twice awarded Lightbridge to support the development of Lightbridge Fuel over the past several years. An extensive worldwide patent portfolio backs Lightbridge’s innovative fuel technology. Lightbridge is included in the Russell 2000®, Russell 3000®, and Solactive Global Uranium and Nuclear Components Total Return Indexes. For more information, please visit www.ltbridge.com.
To receive Lightbridge Corporation updates via e-mail, subscribe at https://www.ltbridge.com/investors/news-events/email-alerts
Lightbridge is on YouTube. Subscribe to access past demonstrations, interviews, and other video content at https://www.youtube.com/@lightbridgecorporation
Lightbridge is on X (formerly Twitter). Sign up to follow @LightbridgeCorp at http://twitter.com/lightbridgecorp.
Forward Looking Statements
With the exception of historical matters, the matters discussed herein are forward-looking statements. These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to: Lightbridge’s ability to commercialize its nuclear fuel technology; the degree of market adoption of Lightbridge’s product and service offerings; Lightbridge’s ability to fund general corporate overhead and outside research and development costs; market competition; our ability to attract and retain qualified employees; dependence on strategic partners; demand for fuel for nuclear reactors; Lightbridge’s ability to manage its business effectively in a rapidly evolving market; the availability of nuclear test reactors and the risks associated with unexpected changes in Lightbridge’s fuel development timeline; the increased costs associated with metallization of Lightbridge’s nuclear fuel; public perception of nuclear energy generally; changes in the political environment; risks associated with war in Europe and the Middle East; changes in the laws, rules and regulations governing Lightbridge’s business; development and utilization of, and challenges to, Lightbridge’s intellectual property; risks associated with potential shareholder activism; potential and contingent liabilities; as well as other factors described in Lightbridge’s filings with the Securities and Exchange Commission (the “SEC”). Lightbridge does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise, except as required by law. Readers are cautioned not to put undue reliance on forward-looking statements.
A further description of risks and uncertainties can be found in Lightbridge’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and in its other filings with the SEC, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Statements,” all of which are available at http://www.sec.gov/ and www.ltbridge.com.
Investor Relations Contact:
Matthew Abenante, IRC
Senior Director of Investor Relations & Capital Markets
Tel: +1 (347) 947-2093
ir@ltbridge.com
*** tables follow ***
LIGHTBRIDGE CORPORATION
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
| 2026 | 2025 | ||||||
| ASSETS | |||||||
| Current Assets | |||||||
| Cash and cash equivalents | $ | 236,735,081 | $ | 201,862,421 | |||
| Prepaid expenses and other current assets | 1,274,477 | 712,983 | |||||
| Total Current Assets | 238,009,558 | 202,575,404 | |||||
| Other Assets | |||||||
| Prepaid project costs and other long-term assets | 2,755,892 | 1,140,000 | |||||
| Trademarks | 127,187 | 119,391 | |||||
| Total Assets | $ | 240,892,637 | $ | 203,834,795 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | $ | 3,830,512 | $ | 847,451 | |||
| Total Current Liabilities | 3,830,512 | 847,451 | |||||
| Stockholders’ Equity | |||||||
| Preferred stock, | — | — | |||||
| Common stock, | 38,761 | 33,407 | |||||
| Additional paid-in capital | 441,219,021 | 386,719,120 | |||||
| Accumulated deficit | (204,195,657 | ) | (183,765,183 | ) | |||
| Total Stockholders’ Equity | 237,062,125 | 202,987,344 | |||||
| Total Liabilities and Stockholders’ Equity | $ | 240,892,637 | $ | 203,834,795 | |||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended | Nine Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Revenue | $ | — | $ | — | $ | — | $ | — | |||||||
| Operating Expenses | |||||||||||||||
| General and administrative | 5,039,852 | 3,164,343 | 13,084,565 | 9,146,989 | |||||||||||
| Research and development | 5,300,753 | 2,039,857 | 12,556,332 | 5,345,635 | |||||||||||
| Total Operating Expenses | 10,340,605 | 5,204,200 | 25,640,897 | 14,492,624 | |||||||||||
| Operating Loss | (10,340,605 | ) | (5,204,200 | ) | (25,640,897 | ) | (14,492,624 | ) | |||||||
| Other Income | |||||||||||||||
| Interest income | 2,009,488 | 1,104,955 | 5,210,423 | 2,101,933 | |||||||||||
| Total Other Income | 2,009,488 | 1,104,955 | 5,210,423 | 2,101,933 | |||||||||||
| Net Loss Before Income Taxes | (8,331,117 | ) | (4,099,245 | ) | (20,430,474 | ) | (12,390,691 | ) | |||||||
| Income taxes | — | — | — | — | |||||||||||
| Net Loss | $ | (8,331,117 | ) | $ | (4,099,245 | ) | $ | (20,430,474 | ) | $ | (12,390,691 | ) | |||
| Net Loss Per Common Share | |||||||||||||||
| Basic and diluted | $ | (0.23 | ) | $ | (0.16 | ) | $ | (0.62 | ) | $ | (0.55 | ) | |||
| Weighted Average Number of Common Shares Outstanding | |||||||||||||||
| Basic and diluted | 35,470,698 | 25,624,598 | 33,152,970 | 22,498,638 | |||||||||||
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | |||||||
| 2026 | 2025 | ||||||
| Operating Activities | |||||||
| Net Loss | $ | (20,430,474 | ) | $ | (12,390,691 | ) | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
| Stock-based compensation | 6,323,764 | 3,746,642 | |||||
| Changes in operating assets and liabilities: | |||||||
| Prepaid expenses and other current assets | (486,494 | ) | (808,317 | ) | |||
| Prepaid project costs and other long-term assets | (1,615,892 | ) | 201,657 | ||||
| Accounts payable and accrued liabilities | 2,977,061 | 1,135,512 | |||||
| (13,232,035 | ) | (8,115,197 | ) | ||||
| Investing Activities | |||||||
| Trademarks | (7,796 | ) | (6,117 | ) | |||
| (7,796 | ) | (6,117 | ) | ||||
| Financing Activities | |||||||
| Proceeds from sale of common stock in public offerings | 50,655,941 | 124,659,368 | |||||
| Issuance costs related to sale of common stock in public offerings | (1,774,741 | ) | (4,207,920 | ) | |||
| Net proceeds from the exercise of stock options | 10,807 | 1,243,794 | |||||
| Payments for taxes related to net share settlement of equity awards | (779,516 | ) | (234,621 | ) | |||
| Net Cash Provided by Financing Activities | 48,112,491 | 121,460,621 | |||||
| Net Increase in Cash and Cash Equivalents | 34,872,660 | 113,339,307 | |||||
| Cash and Cash Equivalents, Beginning of Period | 201,862,421 | 39,990,827 | |||||
| Cash and Cash Equivalents, End of Period | $ | 236,735,081 | $ | 153,330,134 | |||
Source: 